199192-27-3

Basic information

• Product Name: Imidazo[1,2-a]pyridine-3-carboxaldehyde, 5,6,7,8-tetrahydro- (9CI)
• Synonyms: Imidazo[1,2-a]pyridine-3-carboxaldehyde, 5,6,7,8-tetrahydro- (9CI)
• CAS NO: 199192-27-3
• Molecular Formula: C8H10N2O
• Molecular Weight: 150.1778
• Product Categories: ALDEHYDE;AMINETERTIARY
• Mol File: 199192-27-3.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Imidazo[1,2-a]pyridine-3-carboxaldehyde, 5,6,7,8-tetrahydro- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Imidazo[1,2-a]pyridine-3-carboxaldehyde, 5,6,7,8-tetrahydro- (9CI)(199192-27-3)
• EPA Substance Registry System: Imidazo[1,2-a]pyridine-3-carboxaldehyde, 5,6,7,8-tetrahydro- (9CI)(199192-27-3)

Safety Data

• Hazardous Substances Data: 199192-27-3(Hazardous Substances Data)

Upstream product

• 68-12-2 N,N-dimethyl-formamide 
• 156817-72-0 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine 

Relevant articles and documents

Synthesis, biological evaluation and molecular modelling of sulfonohydrazides as selective PI3K p110α inhibitors

A series of 2-methyl-5-nitrobenzenesulfonohydrazides were prepared and evaluated as inhibitors of PI3K. An isoquinoline derivative shows good selectivity for the p110α isoform over p110β and p110δ, and also demonstrates good in vitro activity in a cell pr

3-‘4-HETEROCYCLYL -1,2,3,-TRIAZOL-1-YL!-N-ARYL-BENZAMIDES AS INHIBITORS OF THE CYTOKINES PRODUCTION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES

Disclosed compounds of formula (I), which inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.

BENZAZEPINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE

The present invention provides a novel benzazepine derivative represented by formula : wherein, R1 is a 5- or 6-membered aromatic ring, R2 is lower alkyl group, etc., Y is an optionally substituted imino group, ring A and ring B are independently an optionally substituted aromatic ring, W is formula -W1-X2-W2- (W1 and W2 are independently S(O)m1 (m1 is 0, 1 or 2), etc., and X2 is an optionally substituted alkylene groupetc. ), a preparation method and use thereof.

Bu3SnH mediated oxidative radical cyclisation onto imidazoles and pyrroles

A new protocol using radical cyclisation has been developed for the synthesis of [1,2-c]-fused imidazoles and [1,2-a]-fused pyrroles. The intermediate nucleophilic N-alkyl radicals, generated using Bu3SnH from N- (ω-bromoalkyl) or N-[ω-(phenylselanyl)alkyl] imidazoles and pyrroles, undergo regio-selective radical cyclisalion onto the azole rings followed by oxidative re-aromatisation.

Oxidative radical cyclisations onto imidazoles and pyrroles using Bu3SnH

Oxidative radical cyclisation using Bu3SnH has been used for the synthesis of [1,2-c]-fused imidazoles and [1,2-a]-fused pyrroles from imidazolecarbaldehydes and acylpyrroles respectively. The intermediate nucleophilic N-alkyl radicals cyclise onto imidazole and pyrrole rings followed by oxidative re-aromatisation.